Consequently, the genes and pathways influenced by canonical MED19 overexpression in LNCaP cells under androgen deprivation differ from those governed by alternative MED19, providing complementary oncogenic properties to prostate cancer cells. The gene discussed is MED19; the disease is prostate cancer.